2&l=ur1&category=ce_tradein_iphone&banner=1TXDF1YDARC665JV8FG2&f=ifr&lc=pf4&linkID=ZJDKE46AUWX27BLT" style="border: none;" width="300"> A ,New heart failure drug from Novartis cut the risk of both cardiovascular death and hospitalization by a fifth in keenly awaited study, boosting hopes for a product that is seen as a multimillion-dollar seller . There have been little progress for more than a decade in treating chronic heart failure, in which the heart fails to pump blood around the body. The study compar...